News | Advanced Visualization | November 21, 2016

Arterys Showcases FDA-cleared 4D Flow MRI Software at RSNA 2016

Software for advanced visualization of 4-D cardiac flow, volumetry and function to be displayed at GE Healthcare booth

Arterys, 4-D Flow software, cardiac MRI, RSNA 2016

November 21, 2016 — Arterys will showcase its recently U.S. Food and Drug Administration (FDA) 510(k)-cleared Arterys Software platform at the upcoming Radiological Society of North America (RSNA) 2016 meeting, Nov. 27-Dec. 1 in Chicago. The company will also present new data on cardiac clinical applications using the Arterys 4-D Flow software during the RSNA poster sessions.

Arterys received 510(k) clearance from the FDA for its Arterys Software earlier this month, paving the way for use in clinical settings for the quantification of cardiac flow. This includes 4-D Flow and 2-D Phase Contrast workflows, and cardiac function measurements. Arterys plans on launching the product in the United States through a partnership with GE Healthcare's ViosWorks product.

Arterys representatives will be on hand at the GE Healthcare booth to help demonstrate how the product integrates with ViosWorks to provide comprehensive visualization and quantification of the cardiac anatomy, function and flow. Powered by the Arterys software, ViosWorks will be the first clinically available cardiovascular solution that delivers cloud-based, real-time processing of images with resolutions previously unattainable, according to the company.

Arterys will also host three expert sessions in the Quantitative Imaging Reading Room to provide 4-D Flow magnetic resonance imaging (MRI) software demonstrations on applications of cardiac flow 4-D MRI, and cardiac volumetry and function features. Arterys medical experts will also discuss how deep learning can be applied to automate measurements and provide accurate and consistent cardiac flow and function.

For more information: www.arterys.com

Related Content

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging.

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging. Illustration by Arjun Valiya Parambathu

News | Magnetic Resonance Imaging (MRI) | September 20, 2021
September 20, 2021 — ...
Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI

Getty Images

News | Contrast Media Injectors | September 16, 2021
September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthc
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

Getty Images

News | Lung Imaging | September 15, 2021
September 15, 2021 — Revised guidelines for...
To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud
Feature | Information Technology | September 15, 2021 | By Kumar Goswami
Healthcare organizations today are storing petabytes of medical imaging data — lab slides,...
As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.

Courtesy of Grand View Research

Feature | Magnetic Resonance Imaging (MRI) | September 14, 2021 | By Melinda Taschetta-Millane
Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Feature | Radiology Imaging | September 14, 2021 | By Brendon McHugh
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated AI decision support tool for cardiac ultrasound.
News | Cardiovascular Ultrasound | September 14, 2021
September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S.
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh